BLUE Stock: Breakaway Gap
Bluebird Bio Inc (NASDAQ:BLUE) stock is trading higher on the good news that was disseminated after the close of trading on November 30. The news is actually better than good; it's fantastic. The company's myeloma cancer treatment has delivered significant benefits with no major side effects in patients.
It is actually quite rare that a biotech company releases information from one of its clinical studies that includes no major side effects. This is great news for those unfortunate enough to be suffering from this type of cancer, and it should not be surprising that BLUE stock is surging on the back of this news.
I am actually.
Den vollständigen Artikel lesen ...
Bluebird Bio Inc (NASDAQ:BLUE) stock is trading higher on the good news that was disseminated after the close of trading on November 30. The news is actually better than good; it's fantastic. The company's myeloma cancer treatment has delivered significant benefits with no major side effects in patients.
It is actually quite rare that a biotech company releases information from one of its clinical studies that includes no major side effects. This is great news for those unfortunate enough to be suffering from this type of cancer, and it should not be surprising that BLUE stock is surging on the back of this news.
I am actually.
Den vollständigen Artikel lesen ...